3 QUESTIONS ON . . . The Impact of Historical Redlining on… : Oncology Times
An abstract is unavailable.
Related Articles
The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study
Primary MMRD is more common than previously reported in gliomas in children, adolescents, and young adults, is enriched in specific molecular subgroups, and is associated…
ONS Congress | Oncology Nursing Society
Come together to commemorate oncology nursing’s rich history and be a part of the future of cancer care at the 50th Annual ONS Congress ®!…
Autopsy of a Hemodialysis Machine: Potential for Recycling… : Journal of the American Society of Nephrology
e largest market share, which had met their end-of-use terms (10-12 years of use according to French regulations). Methods One 5008 CorDiax (Fresenius Medical Care…
Allosteric Inhibitors Targeting PIK3CA May Reduce Treatment Toxicities in Breast Cancer
Felipe Batalini, MD, and Alberto Montero, MD, MBA, CPHQ, detail how allosteric inhibitors targeting PIK3CA such as STX-478 may reduce toxicities seen with orthosteric inhibitors.
2024 Most Read Articles | Blood Advances | American Society of Hematology
2024 Most Read Articles | Blood Advances | American Society of Hematology Top Ten Most Read Articles in 2024 Blood Advances is pleased to announce…
Effects of Custom Molded Foot Orthoses on Balance, Gait… : JPO: Journal of Prosthetics and Orthotics
swelling. Foot orthoses increase somatosensory input and shock absorption, thus improving balance, gait speed, and pain. Objectives The aim of this study was to evaluate…
Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by involvement of the skin, bone…
Clive Peedell (@drpeedell.bsky.social)
Consultant Clinical Oncologist NHS advocate and campaigner Politically centre left Wealth inequality creates health inequality
Biomarker-Guided Treatment Approaches Transform Lung and GI Cancer Management
Experts across the fields of lung and GI cancer share key information and insights from 2 recent OncLive biomarker consortiums.